Panic disorder and a possible treatment approach by means of high-frequency rTMS: a case report.
Panic disorder still remains a pervasive, life quality impairing disorder requiring adequate treatment options. In this case report we present the data of a patient with panic disorder and comorbid depression who was treated with high-frequency repetitive transcranial magnetic stimulation (rTMS) applied to the left prefrontal cortex over a course of 3 weeks. Measurements of the cerebral oxygenation with near-infrared spectroscopy (NIRS) during an emotional Stroop task before and after the rTMS treatment suggests that rTMS may modulate panic-related prefrontal brain dysfunctions in panic patients and that it may serve as a possible treatment option for anxiety disorders.
Dresler
Thomas
T
Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital Wuerzburg, Wuerzburg, Germany. Dresler_T@klinik.uni-wuerzburg.de
Ehlis
Ann-Christine
AC
Plichta
Michael M
MM
Richter
Melany M
MM
Jabs
Burkhard
B
Lesch
Klaus-Peter
KP
Fallgatter
Andreas J
AJ
D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000639:Amitriptyline / Q000627:therapeutic use; D017298:Bisoprolol / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D018757:GABA Modulators / Q000627:therapeutic use; D006801:Humans; D008297:Male; D016584:Panic Disorder / Q000188:drug therapy / Q000628:therapy*; D013449:Sulfonamides / Q000627:therapeutic use; D000077409:Tamsulosin; D013693:Temazepam / Q000627:therapeutic use; D050781:Transcranial Magnetic Stimulation / Q000379:methods*
D018759:Adrenergic Uptake Inhibitors; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D018757:GABA Modulators; D013449:Sulfonamides; D000639:Amitriptyline; D013693:Temazepam; D000077409:Tamsulosin; D017298:Bisoprolol